TAK-653 Placebo
TAK-653-1001
Phase 1 small_molecule completed
Quick answer
TAK-653 Placebo for Depressive Disorder is a Phase 1 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Depressive Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed